Non-lamellar lyotropic liquid crystalline nanoparticles as nanocarriers for enhanced drug encapsulation of atorvastatin calcium and proanthocyanidins
Atorvastatin calcium (ATV) and proanthocyanidins (PAC) have a strong antioxidant activity, that can benefit to reduce the atherosclerotic plaque progression. Unfortunately, the bioavailability of ATV is greatly reduced due to its limited drug solubility while the PAC drug is unstable upon exposure t...
Сохранить в:
| Главные авторы: | Maslizan, Mardhiah, Haris, Muhammad Salahuddin, Ajat, Mokrish, Md Jamil, Siti Nurul Ain, Azhar, Shah Christirani, Zahid, N. Idayu, Mat Azmi, Intan Diana |
|---|---|
| Формат: | Статья |
| Опубликовано: |
Elsevier BV
2024
|
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|
Схожие документы
-
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle
по: Maslizan, Mardhiah
Опубликовано: (2022) -
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle
по: Maslizan, Mardhiah
Опубликовано: (2022) -
Formulation and characterization of anti-atherosclerosis drug loaded liquid crystalline nanoparticle /
по: Mardhiah Maslizan, -
Enzyme nanocarriers /
Опубликовано: (2015) -
Nanocarrier Technologies Frontiers of Nanotherapy /
Опубликовано: (2006)
